Baron Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329K Hold
1,309
0.16% 45
2026
Q1
$285K Hold
1,309
0.15% 48
2025
Q4
$299K Hold
1,309
0.16% 45
2025
Q3
$303K Hold
1,309
0.17% 42
2025
Q2
$243K Hold
1,309
0.14% 45
2025
Q1
$274K Hold
1,309
0.17% 42
2024
Q4
$233K Buy
1,309
+41
+3% +$7.54K 0.14% 45
2024
Q3
$250K Hold
1,268
0.15% 43
2024
Q2
$217K Sell
1,268
-125
-9% -$20.7K 0.14% 44
2024
Q1
$254K Hold
1,393
0.16% 46
2023
Q4
$216K Hold
1,393
0.14% 50
2023
Q3
$208K Buy
+1,393
New +$204K 0.13% 45
2023
Q2
Sell
-1,430
Closed -$228K 53
2023
Q1
$228K Hold
1,430
0.14% 47
2022
Q4
$231K Buy
+1,430
New +$219K 0.15% 50
2022
Q3
Sell
-1,393
Closed -$213K 50
2022
Q2
$213K Hold
1,393
0.14% 43
2022
Q1
$226K Hold
1,393
0.13% 45
2021
Q4
$189K Hold
1,393
0.11% 49
2021
Q3
$150K Hold
1,393
0.09% 54
2021
Q2
$157K Hold
1,393
0.1% 52
2021
Q1
$151K Hold
1,393
0.1% 53
2020
Q4
$149K Hold
1,393
0.12% 50
2020
Q3
$122K Buy
+1,393
New +$131K 0.11% 56

Other funds holding ABBV

Baron Financial Group's ABBV Position: Q2 2026 in Review

Baron Financial Group held its AbbVie (ABBV) position steady in Q2 2026 at 1,309 shares worth $329K. The position accounts for 0.16% of the portfolio, ranked #45.

Baron Financial Group first reported a position in ABBV in Q3 2020 and has held it in 22 quarters since. 989 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Baron Financial Group held 1,309 shares of AbbVie worth $329K as of Q2 2026.
  • Baron Financial Group left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.16% of Baron Financial Group's portfolio in Q2 2026, its #45 holding.
  • Baron Financial Group first reported a position in AbbVie in Q3 2020 and has held it in 22 quarters since.
  • 989 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Baron Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.